NCT01052389 Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia Status COMPLETED Phase PHASE4
NCT01051414 An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject Status COMPLETED Phase PHASE2
NCT01046864 Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) Status COMPLETED Phase PHASE1
NCT01046682 Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults Status COMPLETED Phase PHASE2
NCT01046422 Safety Study of BMS-770767 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01042977 Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT01039194 Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER) Status COMPLETED Phase PHASE1
NCT01037166 Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy Status COMPLETED Phase PHASE2
NCT01037062 An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B Infection Status COMPLETED Phase PHASE2
NCT01033500 Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients Status WITHDRAWN Phase NA
NCT01031680 Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension Status COMPLETED Phase PHASE3
NCT01030718 Rollover Study of BMS-354825 in Patients With CML and Ph+ALL Status COMPLETED Phase PHASE1/PHASE2
NCT01030432 Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin Status COMPLETED Phase PHASE2
NCT01024231 Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma Status COMPLETED Phase PHASE1
NCT01024101 Early Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Advanced or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01024062 Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT01023204 Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Breast Cancer Status COMPLETED Phase PHASE2